Eligibility criteria for programmed death receptor 1 inhibitors vs. real-world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck

Br J Dermatol. 2022 Feb;186(2):371-372. doi: 10.1111/bjd.20774. Epub 2021 Nov 2.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • Head and Neck Neoplasms* / drug therapy
  • Humans
  • Receptors, Death Domain
  • Retrospective Studies
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / pathology
  • Squamous Cell Carcinoma of Head and Neck

Substances

  • Receptors, Death Domain